MCID: OVR046
MIFTS: 44

Ovarian Cyst

Categories: Cancer diseases, Endocrine diseases, Reproductive diseases

Aliases & Classifications for Ovarian Cyst

MalaCards integrated aliases for Ovarian Cyst:

Name: Ovarian Cyst 12 6 15
Ovarian Cysts 54 42 15 70

Classifications:



External Ids:

Disease Ontology 12 DOID:5119
ICD9CM 34 620.2
SNOMED-CT 67 198586000
ICD10 32 N83.2
UMLS 70 C0029513 C0029927

Summaries for Ovarian Cyst

MedlinePlus : 42 The ovaries are part of the female reproductive system. They produce a woman's eggs and make female hormones. Ovarian cysts are fluid-filled sacs in or on an ovary. They usually form during ovulation, when the ovary releases an egg. They are usually harmless and go away by themselves. Most women have them sometime during their lives. Most ovarian cysts are small and don't cause symptoms. Women may not find out that they have them until they have a pelvic exam. If there are symptoms, they may include Pressure Bloating Swelling Pain in the lower abdomen, on the side where the cyst is If your health care provider finds a cyst, you may be able to wait to see if it gets bigger. You may need surgery if you have pain, are past menopause, or if the cyst does not go away. If a cyst bursts or causes bleeding, you should get medical help right away. Birth control pills can help prevent new cysts. Rarely, ovarian cysts can become cancerous. This risk increases as you get older. A health problem that involves ovarian cysts is polycystic ovary syndrome (PCOS). Women with PCOS can have high levels of male hormones, irregular or no periods, and small ovarian cysts. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary : Ovarian Cyst, also known as ovarian cysts, is related to malignant ovarian cyst and corpus luteum cyst, and has symptoms including pelvic pain An important gene associated with Ovarian Cyst is MUC16 (Mucin 16, Cell Surface Associated), and among its related pathways/superpathways is Aromatase Inhibitor Pathway (Breast Cell), Pharmacodynamics. The drugs Leuprolide and Danazol have been mentioned in the context of this disorder. Affiliated tissues include ovary, pituitary and uterus, and related phenotypes are endocrine/exocrine gland and liver/biliary system

Disease Ontology : 12 An ovarian disease that is characterized by the presence of a fluid-filled sac and is located in the ovary.

Wikipedia : 73 An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they... more...

Related Diseases for Ovarian Cyst

Diseases in the Ovarian Cyst family:

Malignant Ovarian Cyst

Diseases related to Ovarian Cyst via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 346)
# Related Disease Score Top Affiliating Genes
1 malignant ovarian cyst 32.2 WFDC2 IGFBP2
2 corpus luteum cyst 32.1 MUC16 GNRH1 FOXL2 AFP
3 carney complex variant 31.2 PRL GNAS CNC2
4 cystadenoma 31.1 MUC16 GNAS AFP
5 precocious puberty 30.4 GNRH1 GNAS CYP19A1
6 ovarian serous cystadenocarcinoma 30.4 VEGFA MUC16 GNAS ESR2
7 leiomyoma 30.3 GNRH1 ESR2 CYP19A1
8 ectopic pregnancy 30.3 VEGFA PAEP GNRH1 AFP
9 amenorrhea 30.3 PRL GNRH1 FOXL2 CYP19A1
10 juvenile type testicular granulosa cell tumor 30.2 GNAS FOXL2 AFP
11 hyperandrogenism 30.2 PRL GNRH1 CYP19A1
12 cystadenocarcinoma 30.2 VEGFA MUC16 ESR2
13 myoma 30.0 MUC16 GNRH1 CYP19A1 AMH
14 ovarian hyperstimulation syndrome 29.9 VEGFA GNRH1 CYP19A1 AMH
15 serous cystadenocarcinoma 29.8 VEGFA MUC16 ESR2
16 ovary adenocarcinoma 29.8 VEGFA MUC16 MIR135A1 GNAS
17 pituitary gland disease 29.8 PRL GNRH1 GNAS
18 goiter 29.8 VEGFA PRL GNAS
19 hyperprolactinemia 29.8 PRL GNRH1 GNAS
20 polycystic ovary syndrome 29.7 PRL GNRH1 CYP19A1 AMH
21 mccune-albright syndrome 29.6 PRL GNAS CYP19A1 AMH
22 endometrial hyperplasia 29.6 VEGFA ESR2 CYP19A1
23 adrenal cortical carcinoma 29.6 IGFBP2 GNAS CYP19A1
24 ductal carcinoma in situ 29.6 VEGFA ESR2 CYP19A1
25 adenomyosis 29.5 VEGFA PRL GNRH1 ESR2 CYP19A1
26 gynecomastia 29.5 PRL GNRH1 ESR2 CYP19A1
27 anovulation 29.5 PRL GNRH1 CYP19A1 AMH
28 endometriosis 29.5 VEGFA PAEP MUC16 MIR145 GNRH1 ESR2
29 pituitary tumors 29.4 PRL GNAS CNC2
30 estrogen excess 29.4 PRL GNRH1 FOXL2 ESR2 CYP19A1
31 infertility 29.0 PRL PAEP GNRH1 FOXL2 ESR2 CYP19A1
32 endometriosis of ovary 28.9 MIR145 GNRH1 ESR2 CYP19A1 AMH
33 premature menopause 28.7 PRL GNRH1 FOXL2 ESR2 CYP19A1 AMH
34 endometrial cancer 28.5 VEGFA PAEP MUC16 MIR145 GSTP1 GNRH1
35 ovarian cancer 28.1 WFDC2 VEGFA PAEP MUC16 MIR145 MIR135A1
36 ovarian disease 28.0 VEGFA PRL MUC16 MIR145 MIR135A1 IGFBP2
37 neonatal ovarian cyst 11.4
38 aromatase deficiency 11.2
39 fraser-like syndrome 11.1
40 bleeding disorder, platelet-type, 19 11.0
41 autoimmune oophoritis 11.0
42 lipedematous scalp 11.0
43 adult type testicular granulosa cell tumor 10.4 FOXL2 AFP
44 non-gestational ovarian choriocarcinoma 10.4 PRL AFP
45 ovarian gonadoblastoma 10.3 PRL AFP
46 teratoma 10.3
47 urachal adenocarcinoma 10.3 GNAS AFP
48 glomeruloid hemangioma 10.3 VEGFA PRL
49 fibrous dysplasia/mccune-albright syndrome 10.3 PRL GNAS
50 pyometritis 10.3 PRL GNRH1

Graphical network of the top 20 diseases related to Ovarian Cyst:



Diseases related to Ovarian Cyst

Symptoms & Phenotypes for Ovarian Cyst

UMLS symptoms related to Ovarian Cyst:


pelvic pain

MGI Mouse Phenotypes related to Ovarian Cyst:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.81 AFP AMH CYP19A1 ESR2 FOXL2 GNAS
2 liver/biliary system MP:0005370 9.56 AFP CYP19A1 ESR2 GNAS GNRH1 IGFBP2
3 neoplasm MP:0002006 9.23 AFP AMH ESR2 GNAS GNRH1 GSTP1

Drugs & Therapeutics for Ovarian Cyst

Drugs for Ovarian Cyst (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 75)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Leuprolide Approved, Investigational Phase 4 53714-56-0 3911 657181
2
Danazol Approved Phase 4 17230-88-5 28417
3
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
4
Letrozole Approved, Investigational Phase 4 112809-51-5 3902
5 Antineoplastic Agents, Hormonal Phase 4
6 Hormone Antagonists Phase 4
7 Hormones Phase 4
8 Anti-Inflammatory Agents Phase 4
9 Fenugreek seed meal Phase 4
10 Fenugreek Phase 4
11 Estrogens Phase 4
12 Estrogen Receptor Antagonists Phase 4
13 Estrogen Antagonists Phase 4
14 Analgesics, Non-Narcotic Phase 4
15 Cyclooxygenase 2 Inhibitors Phase 4
16 Analgesics Phase 4
17 Cyclooxygenase Inhibitors Phase 4
18 Antirheumatic Agents Phase 4
19 Anti-Inflammatory Agents, Non-Steroidal Phase 4
20 Aromatase Inhibitors Phase 4
21
Ethinyl Estradiol Approved Phase 2, Phase 3 57-63-6 5991
22
Polyestradiol phosphate Approved Phase 2, Phase 3 28014-46-2
23
Estradiol Approved, Investigational, Vet_approved Phase 2, Phase 3 50-28-2 5757
24
Norgestimate Approved, Investigational Phase 2, Phase 3 35189-28-7 6540478
25
Morphine Approved, Investigational Phase 3 57-27-2 5288826
26
Ropivacaine Approved Phase 3 84057-95-4 71273 175805
27
Buserelin Approved, Investigational Phase 3 57982-77-1
28 Contraceptives, Oral Phase 2, Phase 3
29 Contraceptives, Oral, Combined Phase 2, Phase 3
30 Estradiol 17 beta-cypionate Phase 2, Phase 3
31 Estradiol 3-benzoate Phase 2, Phase 3
32 Contraceptive Agents Phase 2, Phase 3
33 Hemostatics Phase 3
34 Anesthetics Phase 3
35 Anesthetics, Local Phase 3
36 Follicle Stimulating Hormone Phase 3
37
Ephedrine Approved Phase 1, Phase 2 299-42-3 9294
38
Phenylephrine Approved Phase 1, Phase 2 59-42-7 6041
39
Esmolol Approved Phase 1, Phase 2 103598-03-4, 81147-92-4 59768
40
Pseudoephedrine Approved Phase 1, Phase 2 90-82-4 7028
41
Oxymetazoline Approved, Investigational Phase 1, Phase 2 1491-59-4 4636
42 Pharmaceutical Solutions Phase 1, Phase 2
43 Adrenergic alpha-Agonists Phase 1, Phase 2
44 Neurotransmitter Agents Phase 1, Phase 2
45 Cardiotonic Agents Phase 1, Phase 2
46 Vasoconstrictor Agents Phase 1, Phase 2
47 Respiratory System Agents Phase 1, Phase 2
48 Adrenergic Antagonists Phase 1, Phase 2
49 Adrenergic Agents Phase 1, Phase 2
50 Mydriatics Phase 1, Phase 2

Interventional clinical trials:

(show all 49)
# Name Status NCT ID Phase Drugs
1 Comparative Study Between ICSI Results in Transvaginal Ultrasound Guided Embryo Transfer and Transabdominal Ultrasound Guided Embryo Transfer Unknown status NCT03683043 Phase 4 Long GnRH agonist protocol
2 The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation Unknown status NCT01631253 Phase 4
3 The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Exc Completed NCT00713778 Phase 4
4 A Random Clinical Trial of the Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst Completed NCT00746278 Phase 4
5 Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome Completed NCT02789488 Phase 4
6 Treatment With Danazol Before Controlled Ovarian Hyperstimulation in Women With Endometriosis Undergoing IVF Completed NCT01779232 Phase 4 Danazol;placebo
7 Pain Post Abdominal Laparoscopy Prevention With Arcoxia Completed NCT00565682 Phase 4 etoricoxib 120 mg
8 The Role of Estrogen in Luteinizing Hormone Surge and Ovulation Completed NCT01999569 Phase 4 Letrozole
9 Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women? (Randomized Controlled Study) Unknown status NCT03357640 Phase 2, Phase 3 combined oral contraceptive pills
10 Additional Benefit of Hemostatic Sealant in Preserving Ovarian Reserve During Laparoscopic Ovarian Cystectomy: a Randomized Controlled Trial Completed NCT01857466 Phase 3
11 Do Peritoneal Nebulization of Ropivacaine Reduce the Use of Morphine After Short Gynecologic Laparoscopic Surgery? Completed NCT01142622 Phase 3 Ropivacaine nebulization;Ropivacaine instillation
12 Single Port Laparoscopy Versus Conventional Laparoscopy for Benign Adnexal Disease - A Randomized Controlled Trial. Completed NCT01288599 Phase 3
13 A Single Center, Randomized, Investigator-initiated Phase III Trial to Evaluate the Efficacy of Preservation of Ovarian Function and Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy Completed NCT03374397 Phase 3 Surgiguard
14 Prospective, Randomized Open Trial to Evaluate the Efficacy of an Ovarian Stimulation Protocol Based on FSH Receptor Genotype Suspended NCT00749853 Phase 3 follicle stimulating hormone;follicle stimulating hormone
15 A Prospective, Controlled, Randomized, Multi-Center, Pivotal Study Evaluating the Safety and Efficacy of AdhexilTM in Prevention And/Or Reduction of Adhesions in Gynecology Surgery Suspended NCT00865488 Phase 3
16 The Effects of ß1-receptor Blockade and α1-adrenergic Agonist on the Kinetics of Lactated Ringer's Solution During Surgery Completed NCT01431612 Phase 1, Phase 2 Esmolol administration;Phenylephrine infusion;Lactated Ringer´s solution
17 Prognosis and Long Term Pubertal Outcome of Girls Previously Diagnosed With a Prenatal Ovarian Cyst Unknown status NCT02482467
18 Monitoring Ovarian Cysts in Pregnancy Unknown status NCT03440931
19 Laparoscopy-assisted Ovarian Cystectomy: NEW APPROCH Unknown status NCT03370952
20 The Efficacy of Progestins in Treatment of Functional Ovarian Cyst Unknown status NCT03456570 Early Phase 1 Dydrogesterone 10 mg;Placebo Oral Tablet
21 The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts: Randomization Clinical Trial Unknown status NCT03585309
22 A New Algorithm to Predict Ovarian Age Combining Clinical, Biochemical and 3D-ultrasonographic Parameters: OvAge Unknown status NCT02086318
23 Unexplained Infertility Treated by Hysteroscopy-laparoscopy : Predictive Factors of Pregnancy Completed NCT04465045
24 Impact of Laparoscopic Ovarian Cystectomy Versus Aspiration and Coagulation on Ovarian Reserve and Pelvic Pain in Cases of Ovarian Endometrioma Completed NCT03615352
25 Comparison Between Abstention and Intrauterine Aspiration in the Treatment of Anechoic Fetal Ovarian Cysts to Prevent Ovarian Torsion Completed NCT00222066
26 Retrospective Multi-institutional Survey of Clinical Characteristics in Ovarian Clear Cell Adenocarcinoma Cancer Patients Completed NCT02129036
27 Transvaginal Ultrasound Training for the Obstetrics and Gynecology Resident: A Multi-Site Randomized Controlled Trial of Educational DVD Completed NCT02890914
28 Mesial Incision for Laparoscopic Dermoid Cystectomy: a New Safe and Fertility-sparing Technique Completed NCT01590030
29 3-dimensional Versus 2-dimensional Laparoscopy Of Ovarian Cyst (LOOC): a Randomized Controlled Trial Completed NCT03453333
30 The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve : A Prospective Study Completed NCT02852447
31 Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis Completed NCT03193671
32 A Prospective, Multi-Centre, Randomized, Safety and Effectiveness Study of PerClot Compared to Usual Care When Used During Gynaecology Procedures Completed NCT02835391
33 Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome Completed NCT03713138
34 Comparison of Optic Nerve Sheath Diameter According to Position During Laparoscopy Completed NCT01937104 Desflurane;Remifentanil
35 The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position Completed NCT01379313
36 To Study the Efficacy and Safety of Furocyst in Poly Cystic Ovary Syndrome Patients (PCOS) Completed NCT02703064
37 The Affect of Hemostasis With Bipolar Coagulation Versus SURGIFLO Placement on Ovarian Reserve and Future Fertility Recruiting NCT03109964
38 Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy Recruiting NCT04355312
39 Pubertal Evolutionary Profile of Children Monitored for Fetal Ovarian Cyst Recruiting NCT04526392
40 A Pilot Study to Test Rapid Acquisition of Point of Care Ultrasound for Various Applications Recruiting NCT02831556
41 Real-Time Identification of Lesions and Nerves by Using Indocyanine Green Fluorescent Imaging in Gynecological Surgery Recruiting NCT04224467
42 A Multicentre Study to Examine the Short and Long Term Outcomes of the Conservative Management of Benign-looking Adnexal Masses and the Pre-operative Characterisation of Ovarian Tumours Active, not recruiting NCT01698632
43 23 Hour Surgical Model in a Tertiary Hospital: Evaluation From Patient and Organisational Perspective Active, not recruiting NCT04142203
44 Systematic Proposal of Fertility Preservation by Oocyte Freezing in Case of Benign Ovarian Tumors With High Risk of Recurrence Not yet recruiting NCT03823833
45 Diagnosing Ovarian Cysts - the DOC Study Not yet recruiting NCT04188652
46 A Single-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma Not yet recruiting NCT04643106
47 Laparoendoscopic Single-site Surgery Versus Conventional Multi-port Laparoscopy in Presumed Benign Ovarian Cystectomy: A Randomized Controlled Trial Not yet recruiting NCT04788498
48 Can the Peritoneal Cavity be a Source of Regulatory B Cells to Treat Auto-immune Disease? Terminated NCT03189316
49 Regional Study Into the Performance and Cost-effectiveness of Simple Ultrasound-based Rules Compared to the Currently Used Risk of Malignancy Index in the Diagnosis of Ovarian Cancer Terminated NCT02218502

Search NIH Clinical Center for Ovarian Cyst

Genetic Tests for Ovarian Cyst

Anatomical Context for Ovarian Cyst

The Foundational Model of Anatomy Ontology organs/tissues related to Ovarian Cyst:

19
Ovary

MalaCards organs/tissues related to Ovarian Cyst:

40
Ovary, Pituitary, Uterus, Breast, Thyroid, Appendix, Colon

Publications for Ovarian Cyst

Articles related to Ovarian Cyst:

(show top 50) (show all 4846)
# Title Authors PMID Year
1
Torsion of Functional Adnexal Cysts in Pregnancy: Aspiration and Drainage are Important in Preventing Recurrence. 61 42
33443343 2021
2
Is serum anti-Müllerian hormone (AMH) assay a satisfactory measure for ovarian reserve estimation? A comparison of serum and peritoneal fluid AMH levels. 61 42
32735089 2020
3
The levels of follicular fluid cell-free mitochondrial DNA could serve as a biomarker for pregnancy success in patients with small ovarian endometriosis cysts: A case-control study. 42
33235102 2020
4
Reproductive disturbances in multiple neuroendocrine tumor syndromes. 54 61
19737912 2009
5
Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence. 61 54
19844120 2009
6
Precocious pseudopuberty due to autonomous ovarian cysts: a report of ten cases and long-term follow-up. 61 54
18477555 2008
7
The impact of unabated stimulation by human chorionic gonadotropin on the steroid hormone environment of pregnant rats and the spontaneous expression of ovarian cysts in female progeny. 54 61
18481228 2008
8
Involvement of plasma progesterone, oestradiol-17beta and cortisol in ovulatory response to gonadotropin-releasing hormone in dairy cows with cystic follicles. 61 54
17635773 2007
9
McCune-Albright syndrome and disorders due to activating mutations of GNAS1. 61 54
17937059 2007
10
Myxedema ascites with an extremely elevated CA125 Level: a case report. 54 61
17641444 2007
11
Obligatory roles for follicle-stimulating hormone (FSH), estradiol and androgens in the induction of small polyfollicular ovarian cysts in hypophysectomized immature rats. 61 54
17873331 2007
12
Association between milk production and treatment response of ovarian cysts in lactating dairy cows using the Ovsynch protocol. 54 61
16650468 2006
13
Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. 61 54
16357519 2006
14
Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors. 54 61
16033064 2005
15
Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer. 54 61
16033074 2005
16
No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. 54 61
15695318 2005
17
[Carney complex: a case report and literature review]. 54 61
15761519 2004
18
Intracystic evaluation of tumor markers in benign and malignant ovarian pathology. 54 61
12013118 2002
19
The development of an oocyte-containing follicle during gonadotrophin-releasing hormone agonist administration. 54 61
11473966 2001
20
Factors influencing serum CA125II levels in healthy postmenopausal women. 61 54
11352859 2001
21
Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. 61 54
11095480 2000
22
Serum CA125 at 11-14 weeks of gestation in women with morphologically normal ovaries. 61 54
10826587 2000
23
Synergistic effects of insulin-like growth factor-I and human chorionic gonadotropin in the rat ovary. 54 61
10726907 2000
24
Insulin has a biphasic effect on the ability of human chorionic gonadotropin to induce ovarian cysts in the rat. 54 61
10459564 1999
25
Follow up of women with simple ovarian cysts detected by transvaginal sonography in the Tokyo metropolitan area. 54 61
10430190 1999
26
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. 54 61
9850067 1998
27
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues. 61 54
9866068 1998
28
CA-125 and carcinoembryonic antigen assay vs. cytodiagnostic experience in the classification of benign ovarian cysts. 54 61
9305384 1997
29
[A patient with bronchial asthma and mucoid impaction who presented with a high concentration of carcinoembryonic antigen in serum]. 61 54
9366164 1997
30
Inhibin assays of ovarian cyst liquid obtained by needle aspiration may allow differential diagnosis between functional and organic cysts. 61 54
9228498 1997
31
The behavior of follicle cysts formed after long-acting gonadotropin-releasing hormone analog administration in patients with polycystic ovarian syndrome. 54 61
9174850 1997
32
Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis. 61 54
8988701 1997
33
The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment. 54 61
9443032 1997
34
Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid. 54 61
8624265 1996
35
[Hydatidiform mole in Vietnam. The contribution of ultrasonography]. 61 54
7899773 1995
36
Persistent elevation of serum oestradiol levels by functional ovarian cysts despite effective pituitary desensitization with GnRH agonists. 61 54
8187299 1994
37
Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats. 61 54
1640871 1992
38
Serous ovarian cyst fluids contain high levels of endometrial placental protein 14. 61 54
1626182 1992
39
Circulating hormone concentrations in hypothyroid rats with induced polycystic ovaries. 61 54
1924408 1991
40
Effect of intracavitary radiotherapy on tumor-associated trypsin inhibitor (TATI) in patients with cervical and endometrial cancer. 54 61
2354815 1990
41
Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology. 54 61
1696873 1990
42
Mis-diagnosed giant ovarian cyst and ventriculoperitoneal shunt malfunction. 61
33166567 2021
43
Gynaecological surgeries in the era of COVID-19 pandemic: a prospective study. 61
33794565 2021
44
Diagnosis and resection of a giant ovarian cyst presenting in a young patient with contralateral back pain and lower limb deep vein thrombosis. 61
33727290 2021
45
Ovarian cysts disappear after 14-day oral regimen of Korean red ginseng extract in letrozole-induced polycystic ovarian syndrome. 61
33743577 2021
46
Adnexal Torsion: Review of Radiologic Appearances. 61
33577417 2021
47
Histomorphological and Functional Features of the Eutopic Endometrium in Patients with Ovarian Endometriosis After Surgery-a Clinical Study. 61
33650096 2021
48
Inflammation and reproductive function in women with polycystic ovary syndrome. 61
33739372 2021
49
Aberrant Expression of Sodium-Potassium-Chloride Cotransporter in Endometriosis. 61
33709377 2021
50
Trends and outcomes of ruptured ovarian cysts. 61
33712434 2021

Variations for Ovarian Cyst

Expression for Ovarian Cyst

Search GEO for disease gene expression data for Ovarian Cyst.

Pathways for Ovarian Cyst

Pathways related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.23 ESR2 CYP19A1

GO Terms for Ovarian Cyst

Cellular components related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.65 WFDC2 VEGFA PRL PAEP MUC16 IGFBP2
2 extracellular region GO:0005576 9.4 WFDC2 VEGFA PRL PAEP MUC16 IGFBP2

Biological processes related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to estradiol GO:0032355 9.13 IGFBP2 GSTP1 CYP19A1
2 female pregnancy GO:0007565 8.92 PRL IGFBP2 GNRH1 GNAS

Molecular functions related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.8 PRL GNRH1 AMH

Sources for Ovarian Cyst

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....